Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD005011Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 octubre 2003see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Lesiones

Copyright:
  1. Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Janet Birchall

    Transfusion Medicine, Bristol, UK

  • Carolyn Dorée

    Cochrane Ear, Nose and Throat Disorders Group, Department of Otolaryngology, Oxford, UK

  • Ravi Gill

    Department of Anaesthetics, Southampton University Hospital NHS Trust, Southampton, UK

  • David Keeling

    Haemophilia & Thrombosis, Radcliffe Hospitals NHS Trust, Oxford, UK

  • Brian McClelland

    Transfusion Medicine, Scottish National Blood Service, Edinburgh, Other

  • Simon Stanworth

    Correspondencia a: Systematic Review Initiative, National Blood Service, Oxford, UK

    [email protected]

Contributions of authors

CAROLYN DOREE: Protocol development, searching, selection of studies, eligibility and quality assessment, data extraction and analysis.
SIMON STANWORTH: Protocol development, searching, selection of studies, eligibility and quality assessment, data extraction and analysis and content expert.
JANET BIRCHILL: Protocol development, searching, selection of studies, eligibility and quality assessment, data extraction and analysis and content expert.
RAVI GILL: Protocol development, data analysis and content expert.
BRIAN McCLEELAND: Protocol development, data analysis and content expert.
DAVID KEELING: Protocol development, data analysis and content expert.

Sources of support

Internal sources

  • National Blood Service, Research and Development, UK.

External sources

  • No sources of support supplied

Declarations of interest

Dr Ravi Gill is receiving funds from Novo Nordisk for consultancy work. However, he has received no sponsorship from the company for his work on this review and he has no financial interest in this intervention.

Version history

Published

Title

Stage

Authors

Version

2012 Mar 14

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Review

Ewurabena Simpson, Yulia Lin, Simon Stanworth, Janet Birchall, Carolyn Doree, Chris Hyde

https://doi.org/10.1002/14651858.CD005011.pub4

2011 Feb 16

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Review

Yulia Lin, Simon Stanworth, Janet Birchall, Carolyn Doree, Chris Hyde

https://doi.org/10.1002/14651858.CD005011.pub3

2007 Apr 18

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Review

Yulia Lin, Simon Stanworth, Janet Birchall, Carolyn Doree, Chris Hyde

https://doi.org/10.1002/14651858.CD005011.pub2

2003 Oct 20

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Protocol

Janet Birchall, Carolyn Dorée, Ravi Gill, David Keeling, Brian McClelland, Simon Stanworth

https://doi.org/10.1002/14651858.CD005011

Keywords

MeSH